Market Research Logo

Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 provides an overview of Herpes Simplex Virus (HSV) Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Herpes Simplex Virus (HSV) Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Herpes Simplex Virus (HSV) Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Herpes Simplex Virus (HSV) Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Herpes Simplex Virus (HSV) Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Herpes Simplex Virus (HSV) Diagnostic Tests Overview
3 Products under Development
3.1 Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Territory
3.3 Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Estimated Approval Date
4 Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Herpes Simplex Virus (HSV) Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
5 Herpes Simplex Virus (HSV) Diagnostic Tests Companies and Product Overview
5.1 Becton, Dickinson and Company Company Overview
5.1.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
5.2 Biokit, S.A. Company Overview
5.2.1 Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cepheid Company Overview
5.3.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.4 Da An Gene Co., Ltd. Company Overview
5.4.1 Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 DiaSorin S.p.A Company Overview
5.5.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
5.6 Genera Biosystems Limited Company Overview
5.6.1 Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview
5.7 Hologic, Inc. Company Overview
5.7.1 Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 OPKO Health, Inc. Company Overview
5.8.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Qiagen N.V. Company Overview
5.9.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Roche Diagnostics International Ltd. Company Overview
5.10.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Theranos, Inc. Company Overview
5.11.1 Theranos, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 University of Texas Medical Branch at Galveston Company Overview
5.12.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.13 VEGA Ltd Company Overview
5.13.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Herpes Simplex Virus (HSV) Diagnostic Tests - Recent Developments
6.1 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market
6.2 May 16, 2016: Luminex to Highlight ARIES System at the 2016 Clinical Virology Symposium
6.3 May 11, 2016: Theranos Announces Expansion of Board of Directors and New Organizational Structure
6.4 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results
6.5 Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay
6.6 Feb 22, 2016: Luminex Receives Medical Device License for ARIES HSV 1&2 Assay in Canada
6.7 Nov 03, 2015: SeraCare Life Sciences Announces Early Access Programs for ctDNA and RNA Fusion Reference Materials
6.8 Oct 07, 2015: Luminex Corporation Receives FDA Clearance for ARIES HSV 1&2 Assay
6.9 Sep 03, 2015: Focus Diagnostics Receives FDA Clearance to Add Genital Swab Claim to Moderate Complexity Simplexa HSV 1 & 2 Direct Molecular Test
6.10 Jul 29, 2015: SeraCare Life Sciences Unveils Rebranding Initiative to Support Company’s Expanding Capabilities for Precision Diagnostics
6.11 Jul 20, 2015: Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene HSV 1
6.12 Jul 20, 2015: Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene HSV 2
6.13 Jul 14, 2015: Luminex Submits FDA 510(k) Submission for ARIES HSV 1&2 Assay
6.14 Jul 02, 2015: FDA Clears Theranos’s Herpes Simplex 1 Virus IgG Test
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Territory
Table 3: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Herpes Simplex Virus (HSV) Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 6: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
Table 7: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
Table 8: BD Viper LT HSV 1/2 Assay - Product Status
Table 9: BD Viper LT HSV 1/2 Assay - Product Description
Table 10: Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 11: BIO-FLASH HSV 1+2 IgM Assay - Product Status
Table 12: BIO-FLASH HSV 1+2 IgM Assay - Product Description
Table 13: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Xpert HSV 1 And 2 Test - Product Status
Table 15: Xpert HSV 1 And 2 Test - Product Description
Table 16: Xpert HSV CSF Assay - Product Status
Table 17: Xpert HSV CSF Assay - Product Description
Table 18: Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Real Time PCR Kit - HSV General Type - Product Status
Table 20: Real Time PCR Kit - HSV General Type - Product Description
Table 21: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Diagnostic Assay - HSV M + cntr - Product Status
Table 23: Diagnostic Assay - HSV M + cntr - Product Description
Table 24: Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Status
Table 26: Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Description
Table 27: Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Panther System - HSV-1 Assay - Product Status
Table 29: Panther System - HSV-1 Assay - Product Description
Table 30: Panther System - HSV-2 Assay - Product Status
Table 31: Panther System - HSV-2 Assay - Product Description
Table 32: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: mChip - Herpes - Product Status
Table 34: mChip - Herpes - Product Description
Table 35: Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
Table 36: QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Status
Table 37: QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Description
Table 38: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Cobas 6000 Analyzer Series With c501/e601 HSV-2 Test - Product Status
Table 40: Cobas 6000 Analyzer Series With c501/e601 HSV-2 Test - Product Description
Table 41: Cobas 6000 Analyzer Series With c501/e601 Module - HSV-1 Test - Product Status
Table 42: Cobas 6000 Analyzer Series With c501/e601 Module - HSV-1 Test - Product Description
Table 43: Cobas 8000 Analyzer Series With c 701 Module - HSV Type I And II Assay - Product Status
Table 44: Cobas 8000 Analyzer Series With c 701 Module - HSV Type I And II Assay - Product Description
Table 45: Cobas 8000 Analyzer Series With c 702 Module - HSV Type I and II Assay - Product Status
Table 46: Cobas 8000 Analyzer Series With c 702 Module - HSV Type I and II Assay - Product Description
Table 47: Theranos, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 48: HSV-1 IgG Test - Capillary Plasma - Product Status
Table 49: HSV-1 IgG Test - Capillary Plasma - Product Description
Table 50: HSV-1 IgG Test - Capillary Whole Blood - Product Status
Table 51: HSV-1 IgG Test - Capillary Whole Blood - Product Description
Table 52: HSV-1 IgG Test - Venous Plasma - Product Status
Table 53: HSV-1 IgG Test - Venous Plasma - Product Description
Table 54: HSV-1 IgG Test - Venous Serum - Product Status
Table 55: HSV-1 IgG Test - Venous Serum - Product Description
Table 56: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Diagnostic Assay - HSV - Product Status
Table 58: Diagnostic Assay - HSV - Product Description
Table 59: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Enzyme Immunoassay - HSV2 - Product Status
Table 61: Enzyme Immunoassay - HSV2 - Product Description
Table 62: Glossary
1.2 List of Figures
Figure 1: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Territory
Figure 3: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report